Open access to the KCNQ channel: Retigabine and second generation M-current openers

Chapter 10 in: Cox B & Gosling M (Eds.) Ion Channel Drug Discovery. Krupp, J.; Rush, A.M.; Swahn, B.; Main M. Royal Society of Chemistry Publishing. 2015, 238-257

View

Recommended Publications

Latest Publications

Activation of TREK-1 and TREK-2 Two-Pore Domain Potassium Channels by the Kv4 Channel Modulator, NS5806

NS5806, widely used as a Kv4-selective activator, also activates TREK-1 and TREK-2 potassium channels.

Beyond Hybridisation: Biologically Meaningful Protein Interactions of Oligonucleotides

Nature Communications paper ‘The nucleobase guanine at the 3′-terminus of oligonucleotide RGLS4326 drives off-target AMPAR inhibition and CNS toxicity'

View All

Activation of TREK-1 and TREK-2 Two-Pore Domain Potassium Channels by the Kv4 Channel Modulator, NS5806

Future-proof cardiac safety: Scalable hiPSC cardiomyocyte new approach methodologies (NAMs) that de-risk earlier and strengthen IND packages

View All